No earnings within 2 weeks of this transaction.
| Insider | Akinsanya Karen |
|---|---|
| Title | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
| Transaction Date | Sep 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Sep 21, 2026 |
| Shares Sold | 10,000 |
| Price per Share | $28.00 |
| Total Value | $280,000.00 |
| Shares Owned After | 91,555 |
| Derivative | No |
| Accession Number | 0001797672-26-000006 |
| Document | View SEC Filing |